COMPANY
CrossLife Technologies Inc.
CrossLife Technologies is a life sciences company. From company website Source · Oct 12, 2026
Timeline
- Grant Government grant — SBIR: $994,439 (annual award, as published), announced Apr 24, 2025. Agency: NIH/NCI. Source: government award database. source ↗
Funding
- Government grant — SBIR: $994,439 (annual award, as published), announced Apr 24, 2025. Agency: NIH/NCI. Source: government award database. source ↗
NIH awards 25
- NIH award 5R33HD101936-05 FY2024: $759,214 awarded for that fiscal year; activity R33 (OTHER_NIH); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. A Rapid HIV RNA Detection without source ↗
- NIH award 4R44CA250663-02 FY2023: $994,004 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Point of Care HPV 16/18/45 DNA Test for source ↗
- NIH award 4R33HD101936-04 FY2023: $792,894 awarded for that fiscal year; activity R33 (OTHER_NIH); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. A Rapid HIV RNA Detection without source ↗
- NIH award 5R44AI140813-03 FY2022: $999,799 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Rapid Point-of-Care RNA Diagnostic for source ↗
- NIH award 5R61HD101936-03 FY2021: $427,926 awarded for that fiscal year; activity R61 (OTHER_NIH); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. A Rapid HIV RNA Detection without source ↗
- NIH award 4R44AI140813-02 FY2021: $999,799 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Rapid Point-of-Care RNA Diagnostic for source ↗
- NIH award 1R44TR003549-01 FY2021: $999,916 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Point-of-Care Rapid RNA test for Zika source ↗
- NIH award 5R61HD101936-02 FY2020: $489,715 awarded for that fiscal year; activity R61 (OTHER_NIH); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. A Rapid HIV RNA Detection without source ↗
- NIH award 5R44DK123849-02 FY2020: $990,440 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Rapid, Point-of-Care Nucleic Acid Test source ↗
- NIH award 1R44CA250663-01 FY2020: $299,945 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Point of Care HPV 16/18/45 DNA Test for source ↗
- NIH award 1R44DK123849-01 FY2019: $999,841 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Rapid, Point-of-Care Nucleic Acid Test source ↗
- NIH award 1R61HD101936-01 FY2019: $513,445 awarded for that fiscal year; activity R61 (OTHER_NIH); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. A Rapid HIV RNA Detection without source ↗
- NIH award 5R44AI124779-03 FY2019: $995,819 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Point-of-Care Rapid RNA test for HIV source ↗
- NIH award 1R44AI145810-01 FY2019: $299,766 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Rapid, Multiplexed Point-Of-Care Molecu source ↗
- NIH award 1R44AI140813-01A1 FY2019: $299,410 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Rapid Point-of-Care RNA Diagnostic fo source ↗
- NIH contract (government contract; not a grant and not an investment round) 75N93019C00026-0-9999-1 FY2019: $299,974 awarded for that fiscal year; activity N43 (OTHER_NIH); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. POIN source ↗
- NIH contract (government contract; not a grant and not an investment round) 75N91019C00055-0-9999-1 FY2019: $299,987 awarded for that fiscal year; activity N43 (OTHER_NIH); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Poin source ↗
- NIH award 2R44AI124779-02 FY2018: $999,743 awarded for that fiscal year; activity R44 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Point-of-Care Rapid RNA test for HIV source ↗
- NIH contract (government contract; not a grant and not an investment round) 272201800020C-0-0-1 FY2018: $216,444 awarded for that fiscal year; activity N01 (OTHER_NIH); PI n/a; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Diagnostics Devel source ↗
- NIH award 1R43AI129077-01 FY2017: $299,574 awarded for that fiscal year; activity R43 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. A Rapid Paper Strip Nucleic Acid Test f source ↗
- NIH award 1R43AI126927-01 FY2016: $282,084 awarded for that fiscal year; activity R43 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. A Rapid Paper Strip Nucleic Acid Test f source ↗
- NIH award 1R43AI124779-01A1 FY2016: $281,515 awarded for that fiscal year; activity R43 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Point-of-Care Rapid RNA test for HIV source ↗
- NIH award 1R43TR001319-01A1 FY2016: $306,564 awarded for that fiscal year; activity R43 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Point-of-Care Rapid RNA Diagnosis of source ↗
- NIH award 3R43TR001271-01S1 FY2016: $40,000 awarded for that fiscal year; activity R43 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Rapid Point-of-Care Diagnostic for Ear source ↗
- NIH award 1R43TR001271-01 FY2015: $305,232 awarded for that fiscal year; activity R43 (SBIR); PI CHO, HYUNDAE; recipient as written: CROSSLIFE TECHNOLOGIES, INC., CARLSBAD, CA. Rapid Point-of-Care Diagnostic for Earl source ↗